Publication search
with Delay from registration to transplantation as keyword

Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid le...

Allogeneic hematopoietic stem cell transplantation is the only potentially curative therapy for high-risk acute myeloid leukemia. In the absence of an HLA-matched related or unrelated donor (MRD or MUD), the best alternative donor source remains controversial. Umbilical cord blood and haploidentical donors offer a time advantage when considering th...